# A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

> **NCT06780306** · PHASE2 · COMPLETED · sponsor: **BioTissue Holdings, Inc** · enrollment: 74 (actual)

## Conditions studied

- Dry Eye
- Dry Eye Disease (DED)
- Dry Eye Disease With Severe Keratitis

## Interventions

- **BIOLOGICAL:** TTAX03
- **BIOLOGICAL:** Saline (NaCl 0,9 %) (placebo)

## Key facts

- **NCT ID:** NCT06780306
- **Lead sponsor:** BioTissue Holdings, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-12
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780306, "A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06780306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*